222 related articles for article (PubMed ID: 18192112)
21. Identification of genes regulated by 2-methoxyestradiol (2ME2) in multiple myeloma cells using oligonucleotide arrays.
Chauhan D; Li G; Auclair D; Hideshima T; Richardson P; Podar K; Mitsiades N; Mitsiades C; Li C; Kim RS; Munshi N; Chen LB; Wong W; Anderson KC
Blood; 2003 May; 101(9):3606-14. PubMed ID: 12480690
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of PAX5 induces apoptosis in multiple myeloma cells.
Proulx M; Cayer MP; Drouin M; Laroche A; Jung D
Int J Hematol; 2010 Oct; 92(3):451-62. PubMed ID: 20882442
[TBL] [Abstract][Full Text] [Related]
23. Identification of ERdj3 and OBF-1/BOB-1/OCA-B as direct targets of XBP-1 during plasma cell differentiation.
Shen Y; Hendershot LM
J Immunol; 2007 Sep; 179(5):2969-78. PubMed ID: 17709512
[TBL] [Abstract][Full Text] [Related]
24. Human BSAP and BLIMP1 conform an autoregulatory feedback loop.
Mora-López F; Reales E; Brieva JA; Campos-Caro A
Blood; 2007 Nov; 110(9):3150-7. PubMed ID: 17682124
[TBL] [Abstract][Full Text] [Related]
25. The X-box binding protein-1 transcription factor is required for plasma cell differentiation and the unfolded protein response.
Iwakoshi NN; Lee AH; Glimcher LH
Immunol Rev; 2003 Aug; 194():29-38. PubMed ID: 12846805
[TBL] [Abstract][Full Text] [Related]
26. [Molecular mechanism of oncogenesis and progression in human myeloma].
Kawano MM; Otsuyama K
Nihon Rinsho; 2007 Dec; 65(12):2187-93. PubMed ID: 18069259
[TBL] [Abstract][Full Text] [Related]
27. [Effect of low-dose 2-methoxyestradiol on the expressions of two isoforms of PRDM1 gene in myeloma].
Jiang H; Hou J
Zhonghua Xue Ye Xue Za Zhi; 2009 Jan; 30(1):38-41. PubMed ID: 19563034
[TBL] [Abstract][Full Text] [Related]
28. Tissue inhibitor of metalloproteinase 1 (TIMP-1) promotes plasmablastic differentiation of a Burkitt lymphoma cell line: implications in the pathogenesis of plasmacytic/plasmablastic tumors.
Guedez L; Martinez A; Zhao S; Vivero A; Pittaluga S; Stetler-Stevenson M; Raffeld M; Stetler-Stevenson WG
Blood; 2005 Feb; 105(4):1660-8. PubMed ID: 15479729
[TBL] [Abstract][Full Text] [Related]
29. Simultaneous in vivo time course and dose response evaluation for TCDD-induced impairment of the LPS-stimulated primary IgM response.
North CM; Crawford RB; Lu H; Kaminski NE
Toxicol Sci; 2009 Nov; 112(1):123-32. PubMed ID: 19675145
[TBL] [Abstract][Full Text] [Related]
30. [Effect of 2-methoxyestradiol on differentiation of primary myeloma cells].
Gao WR; Hou J; Xiong H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):262-6. PubMed ID: 16638193
[TBL] [Abstract][Full Text] [Related]
31. Id helix-loop-helix proteins antagonize pax transcription factor activity by inhibiting DNA binding.
Roberts EC; Deed RW; Inoue T; Norton JD; Sharrocks AD
Mol Cell Biol; 2001 Jan; 21(2):524-33. PubMed ID: 11134340
[TBL] [Abstract][Full Text] [Related]
32. Dependence of BSAP repressor and activator functions on BSAP concentration.
Wallin JJ; Gackstetter ER; Koshland ME
Science; 1998 Mar; 279(5358):1961-4. PubMed ID: 9506950
[TBL] [Abstract][Full Text] [Related]
33. Blimp-1 siRNA inhibits B cell differentiation and prevents the development of lupus in mice.
Zhou Z; Li A; Wang Z; Pei F; Xia Q; Liu G; Ren Y; Hu Z
Hum Immunol; 2013 Mar; 74(3):297-301. PubMed ID: 23220434
[TBL] [Abstract][Full Text] [Related]
34. Response of myeloma to the proteasome inhibitor bortezomib is correlated with the unfolded protein response regulator XBP-1.
Ling SC; Lau EK; Al-Shabeeb A; Nikolic A; Catalano A; Iland H; Horvath N; Ho PJ; Harrison S; Fleming S; Joshua DE; Allen JD
Haematologica; 2012 Jan; 97(1):64-72. PubMed ID: 21993678
[TBL] [Abstract][Full Text] [Related]
35. Plasma cell differentiation and multiple myeloma.
Shapiro-Shelef M; Calame K
Curr Opin Immunol; 2004 Apr; 16(2):226-34. PubMed ID: 15023417
[TBL] [Abstract][Full Text] [Related]
36. Identification of a functionally impaired positive regulatory domain I binding factor 1 transcription repressor in myeloma cell lines.
Györy I; Fejér G; Ghosh N; Seto E; Wright KL
J Immunol; 2003 Mar; 170(6):3125-33. PubMed ID: 12626569
[TBL] [Abstract][Full Text] [Related]
37. Initiation of plasma-cell differentiation is independent of the transcription factor Blimp-1.
Kallies A; Hasbold J; Fairfax K; Pridans C; Emslie D; McKenzie BS; Lew AM; Corcoran LM; Hodgkin PD; Tarlinton DM; Nutt SL
Immunity; 2007 May; 26(5):555-66. PubMed ID: 17509907
[TBL] [Abstract][Full Text] [Related]
38. Loss of Pax5 promotes plasma cell differentiation.
Nera KP; Kohonen P; Narvi E; Peippo A; Mustonen L; Terho P; Koskela K; Buerstedde JM; Lassila O
Immunity; 2006 Mar; 24(3):283-93. PubMed ID: 16546097
[TBL] [Abstract][Full Text] [Related]
39. Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program.
Shaffer AL; Lin KI; Kuo TC; Yu X; Hurt EM; Rosenwald A; Giltnane JM; Yang L; Zhao H; Calame K; Staudt LM
Immunity; 2002 Jul; 17(1):51-62. PubMed ID: 12150891
[TBL] [Abstract][Full Text] [Related]
40. Induction of apoptosis in plasma cells by B lymphocyte-induced maturation protein-1 knockdown.
Lin FR; Kuo HK; Ying HY; Yang FH; Lin KI
Cancer Res; 2007 Dec; 67(24):11914-23. PubMed ID: 18089822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
